Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Prostate cancer, familial × Clear all
NCT07416812 2026-02-18

IMPACT

Institute of Oncology Ljubljana

Phase NA Completed
25 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT02381015 2019-11-22

Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Endeavor Health

Phase NA Completed
700 enrolled 13 charts
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡